STAT+: Vertex kidney disease drug scrutinized for infection risk

Coverage, in order

1. 13d ago
   
   STAT Biotech indie study

   STAT+: Vertex kidney disease drug scrutinized for infection risk

   This is the online version of Adam’s Biotech Scorecard, a weekly newsletter featuring exclusive, spicy analysis on the biotech industry. Sign up here to get it delivered to your inbox. Spain is amazing. I was in Madrid for five days covering the ESMO conference. Now, I’m delivering this newsletter…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.